scholarly journals Concurrent squamous cell carcinoma and hemangiosarcoma in the cornea of a cat

2016 ◽  
Vol 85 (1) ◽  
pp. 31-35
Author(s):  
G. Storms ◽  
C. Naranjo ◽  
M. Grauwels

A 14-year-old, female, spayed Domestic Shorthair cat was presented for evaluation of a dark red mass occupying about 75% of the cornea of the left eye. Furthermore, the eye presented upper eyelid trichiasis, lower eyelid entropion and a marked symblepharon. The fellow eye presented upper eyelid trichiasis, lower eyelid entropion, extensive symblepharon and chronic stromal ulcerative keratitis. Based on the results of a corneal biopsy of the left eye, a corneal squamous cell carcinoma was diagnosed and an enucleation was performed subsequently. Histopathology of the globe revealed the presence of variably sized, vascular-like, blood-filled channels in the superficial corneal stroma, lined by spindle cells. In the central cornea, a markedly hyperplastic epithelium was noticed with infiltration of atypical corneal epithelial cells into the superficial stroma. A primary corneal hemangiosarcoma associated with a primary corneal squamous cell carcinoma was diagnosed. In this case report, the rare presence of multiple primary neoplasms within the same anatomical structure is described.

2021 ◽  
Vol 49 ◽  
Author(s):  
Yasmin Najm Bortoletto ◽  
Júlia De Assis Arantes ◽  
Alessandra Mayer Coelho ◽  
Lais Maria Gomes ◽  
Manuela Cristine Camargo Lambert ◽  
...  

Background: Equines are routinely subjected to enucleation due to palpebral tumors. Blepharoplasties in horses, especially in the lower eyelid, are rarely performed due to the difficulty of sliding once the tissue around the eyes presents low mobility. Defects involving more than 50% of the lower eyelid is considered challenging after tumor removal. Squamous cell carcinoma (SCC) is the second most reported neoplasm in horses, being very common in regions of the lower eyelid, third eyelid, sclera and or cornea. The aim of this study is to present the Destro VY skin advancement flap as a blepharoplasty technique performed after surgical excision of a SCC, with total commitment of the lower eyelid, completely covering the right eye of a mare.Case: A 8-year-oldmarePaint Horse, weighing420 kg,was referred for evaluation of tumor tissue of 6.0 x 4.0 x 2.0 cm, with nodular and ulcerated appearance, involving the right lower eyelid, in its total extension and completely covering the eye, without adhering to it. Considering the initial suspicion of SCC, the treatment strategy performed was surgical eyelid excision and maintenance of the eye, followed by blepharoplasty as an attempt to reconstruct the eyelid. Under general inhalation anesthesia, the animal was placed in left lateral recumbency, when the surgical region was prepared and local anesthetic block was performed. After antisepsis, a skin incision was made circumscribing the tumor, respecting a margin of 10 mm apart and excision of all visible tumor tissue was performed followed by intralesional ozone therapy. Blepharoplasty was performed to cover the portions of the exposed lacrimal and zygomatic bones, as well as correction of the eyelid aesthetics. For this, Destro VY skin advancement flap was performed for reconstruction of the lower eyelid. An incision of approximately 7 cm in V-shaped skin was performed, and the subcutaneous tissue under the V was dissected, maintaining a central pedicle, responsible for the vascularization of the flap, which was slid, approximately 20 mm, towards the eye. After obtaining the desired skin approximation, Y-suture was performed, covering the exposed bone and reconstructing the lower eyelid. In the postoperative period, local instillation of mitomycin eye drops and systemic meloxicam administration were instituted. The mare had her vision restored, presenting satisfactory morpho functional and aesthetic results and no tumor recurrence during 1-year of follow-up. Discussion: The repair of lower eyelid imperfections is challenging, especially when they have large defects, and there are no reports of performing the Destro VY skin advancement flap technique in horses for lower eyelid reconstruction. In this case, the importance of the blepharoplasty technique is emphasized, avoiding enucleation, preserving horse’s vision and aesthetics. In addition, aiming to avoid tumor recurrence, especially if surgical safety margins can not be achieved, other complementary treatments should be associated, including intralesional ozone therapy, mitomycin, an antineoplastic chemotherapy drug, and meloxicam, a COX-2 selective, non-steroidal anti-inflammatory drug, as performed in this study. It is concluded that the use of the Destro VY skin advancement flap technique for reconstruction of the external lamella in cases of SCC in the lower eyelid of horses is a feasible technique, which preserves the animal's vision, as well as aesthetics. The safety margin in the surgical excision of the SCC and the association of complementary therapies in the resolution of the condition are important points also to be considered.Keywords: epidermoid carcinoma, equine, ophthalmology, plastic surgery, skin tumor. Título: Exérese tumoral seguida de blefaroplastia no tratamento de carcinoma de células escamosas em pálpebra inferior de equino 


2006 ◽  
Vol 130 (3) ◽  
pp. 393-396 ◽  
Author(s):  
Alan D. Proia ◽  
M. Angelica Selim ◽  
Jason C. Reutter ◽  
John J. Michon

Abstract A 93-year-old woman developed a mass on her right lower eyelid that was present for more than 6 months but underwent rapid expansion during several weeks prior to her ophthalmological evaluation. Examination revealed an approximately 1.8 cm in diameter, fleshy, fungating growth involving more than 60% of the right lower eyelid. Excisional biopsy disclosed a neoplasm arising from the epidermis composed of adjoining basal cell and signet-ring squamous cell carcinoma, without a transition zone. The cells comprising the basal and squamous cell carcinomas were distinct immunophenotypically, with only the basal cell carcinoma reacting with Ber-EP4 and CAM 5.2 antibodies. To our knowledge, this case represents the first example of a collision tumor composed of basal cell and signet-ring squamous cell carcinoma.


2018 ◽  
Vol 7 (1) ◽  
pp. 40-46
Author(s):  
Emily C. Jeanes ◽  
Sarah Koll-Hampp ◽  
Charlotte Dawson ◽  
Bettina Dunkel ◽  
Roser Tetas Pont

2021 ◽  
pp. 112067212110163
Author(s):  
Jin-Jhe Wang ◽  
Kam-Fai Lee ◽  
Chau-Yin Chen

Background: Collision tumors are rare clinical entities that two heterogeneous neoplasms are concurrently adjacent to each other at the same location. The association of a squamous cell carcinoma and a malignant adnexal tumor is even infrequent. Case presentation: The case of a 79-year-old woman having a slow-growing and painless tumor on the left lower eyelid was presented. The lesion, about 15 mm in diameter, was nodular, irregular, and yellow-discolored. Histopathologic and immunohistochemical findings disclosed concurrence of sebaceous carcinoma as well as squamous cell carcinoma in one specimen. Wide excision of the tumor with frozen section control and eyelid reconstruction were performed. Oncologic survey revealed no other lesion. At 6-month follow-up, no evidence of recurrence or metastasis was presented. Conclusion: Collision tumor composed of sebaceous carcinoma and squamous cell carcinoma in eyelid may be the first case described in the literature. For increasing accuracy of diagnosis and management, a thorough clinical examination and detailed histopathologic analysis, along with multidisciplinary discussion, are prerequisites.


2021 ◽  
Vol 13 (4) ◽  
pp. 74-77
Author(s):  
Sphoorthi Basavannaiah

Malignant neoplasms of the external auditory canal, middle and inner ear are rare. Squamous cell carcinoma (SCC) is the most common neoplasm to occur in this region. As such primary neoplasms of the external auditory canal and temporal bone are uncommon, as these structures more frequently are involved by the cutaneous squamous cell carcinoma (cSCC) of pinna or metastatic cSCC involving parotid gland or post auricular lymph nodes.


Sign in / Sign up

Export Citation Format

Share Document